NovaBridge Biosciences (NBP) — Long-term Investment Intensity
NovaBridge Biosciences (NBP) has a Long-term Investment Intensity of 2.0% as of September 2025. Long-term investments of $40.32 Million represent 2.0% of total assets of $1.97 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check NovaBridge Biosciences (NBP) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
NovaBridge Biosciences Long-term Investment Intensity (2021–2024)
This chart shows how NovaBridge Biosciences's Long-term Investment Intensity has evolved across 3 annual periods from 2021 to 2024. As of September 2025, the intensity stands at 2.0%, reflecting long-term investments of $40.32 Million against total assets of $1.97 Billion USD. Explore NovaBridge Biosciences cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for NovaBridge Biosciences (2021–2024)
The table below presents the year-by-year Long-term Investment Intensity for NovaBridge Biosciences from 2021 to 2024, covering 3 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see NBP market cap.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2024 | 14.5% | $30.82 Million | $212.68 Million | ▲ +14.4 pp |
| 2022 | 0.1% | $4.47 Million | $4.07 Billion | ▼ -0.9 pp |
| 2021 | 1.0% | $55.24 Million | $5.63 Billion | — |